NanoVibronix, Inc. (NASDAQ:NAOV) Short Interest Down 58.0% in December

NanoVibronix, Inc. (NASDAQ:NAOV) saw a significant decrease in short interest in December. As of December 31st, there was short interest totalling 249,900 shares, a decrease of 58.0% from the December 15th total of 594,600 shares. Based on an average daily volume of 1,380,000 shares, the short-interest ratio is presently 0.2 days. Approximately 6.7% of the shares of the stock are sold short.

NanoVibronix Stock Performance

NanoVibronix stock traded down $0.02 during midday trading on Monday, reaching $0.50. 325,123 shares of the company were exchanged, compared to its average volume of 9,272,259. The firm’s 50-day simple moving average is $0.64 and its 200-day simple moving average is $0.64. NanoVibronix has a 1 year low of $0.46 and a 1 year high of $1.52. The company has a market capitalization of $1.87 million, a price-to-earnings ratio of -0.40 and a beta of 1.64.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.